References
- Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC: Prevalence of obesity and severe obesity in US children, 1999–2016. Pediatrics 2018; 141: e20173459.
- Dyson JK, McPherson S, Anstee QM: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. J Clin Pathol 2013; 66: 1033–1045.
- Goyal NP, Schwimmer JB: The genetics of pediatric nonalcoholic fatty liver disease. Clin Liver Dis 2018; 22: 59–71.
- Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V: Pediatric nonalcoholic fatty liver disease: A multidisciplinary approach. Nat Rev Gastroenterol Hepatol 2012; 9: 152–161.
- Pan JJ, Fallon MB: Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol 2014; 6: 274–283.
- Anderson EL, Howe LD, Jones HE, Higgins JPT, Lawlor DA, Fraser A: The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PloS One 2015; 10: e0140908.
- Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A et al.: Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008; 48: 442–448.
- Armstrong T, Ly KV, Murthy S, Ghahremani S, Kim GH, Calkins KL et al.: Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique. Pediatr Radiol 2018; 48: 941–953.
- Shimizu M, Suzuki K, Kato K, Jojima T, Iijima T, Murohisa T et al.: Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease. Diabetes Obes Metab 2019; 21: 285–292.
- Tolman KG, Fonseca V, Dalpiaz A, Tan MH: Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007; 30: 734–743.
- Byrne CD, Targher G: NAFLD: a multisystem disease. J Hepatol 2015; 62 Suppl: S47–S64.
- Trombetta M, Spiazzi G, Zoppini G, Muggeo M: Review article: type 2 diabetes and chronic liver disease in the verona diabetes study. Aliment Pharmacol Ther 2005; 22 Suppl: 24–27.
- de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V et al.: Liver stiffness measurement in children using FibroScan: Feasibility study and comparison with fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007; 45: 443–450.
- Kim E, Kang Y, Hahn S, Lee MJ, Park YN, Koh H: The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice. Korean J Pediatr 2013; 56: 19–25.
- Shah J, Okubote T, Alkhouri N: Overview of updated practice guidelines for pediatric nonalcoholic fatty liver disease. Gastroenterol Hepatol (N Y) 2018; 14: 407–414.
- Fallatah HI, Akbar HO, Fallatah AM: Fibroscan compared to FIB-4, APRI, and AST/ALT ratio for assessment of liver fibrosis in Saudi patients with nonalcoholic fatty liver disease. Hepat Mon 2016; 16: e38346.
- Mansoor S, Yerian L, Kohli R, Xanthakos S, Angulo P, Ling S et al.: The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Dig Dis Sci 2015; 60: 1440–1447.
- Joo I, Kim SY, Park HS, Lee ES, Kang HJ, Lee JM: Validation of a new point shear-wave elastography method for noninvasive assessment of liver fibrosis: a prospective multicenter study. Korean J Radiol 2019; 20: 1527–1535.
- Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM: Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a united states cohort: the boston children’s hospital experience. J Pediatr 2013; 163: 1058–1064.e2.
- Dhyani M, Gee MS, Misdraji J, Israel EJ, Shah U, Samir AE: Feasibility study for assessing liver fibrosis in paediatric and adolescent patients using real-time shear wave elastography. J Med Imaging Radiat Oncol 2015; 59: 687–694.
- Ferraioli G, Filice C, Castera L, Choi BI, Sporea I, Wilson SR et al.: WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 3: liver. Ultrasound Med Biol 2015; 41: 1161–1179.
- ADA. American Diabetes Association Website. https://www.diabetes.org/a1c/diagnosis. Accessed: 6.01.2020.
- Osman AM, El Shimy A, Abd El Aziz MM: 2D shear wave elastography (SWE) performance versus vibration-controlled transient elastography (VCTE/fibroscan) in the assessment of liver stiffness in chronic hepatitis. Insights Imaging 2020; 11: 38.
- Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH et al.: Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011; 53: 726–736.